 | Vorinostat | IC50 | 1020.0 [1] |
| Vorinostat | Ki | 396.0 [1] |
 | Trichostatin A | IC50 | 300.0 [1] |
| Trichostatin A | Ki | 69.65 [1] |
 | Tubastatin A | IC50 | 854.0 [1] |
| Tubastatin A | Ki | 96.2 [1], 1697.0 [2] |
 | N-Hydroxy-1-(4-methoxybenzyl)-1H-indole-6-carboxamide | IC50 | 77.7 [1] |
 | Entinostat | IC50 | 10000.0 [1] |
 | Panobinostat | IC50 | 231.0 [1] |
| Panobinostat | Ki | 22.0 [1], 105.0 [2], 170.0 [3] |
 | Tubacin | IC50 | 854.0 [1], 1270.0 [2], 5000.0 [3] |
| Tubacin | Ki | 143.1 [1], 170.0 [2] |
 | Belinostat | IC50 | 70.0 [1], 200.0 [2], 353.0 [3] |
| Belinostat | Ki | 22.0 [1], 25.0 [2] |
 | Apicidin | IC50 | 300.0 [1], 750.0 [2], 755.0 [3], 760.0 [4] |
| Apicidin | Ki | 49.0 [1] |
 | Romidepsin | IC50 | 40.0 [1], 10000.0 [2], 50000.0 [3] |
| Romidepsin | Ki | 0.15 [1] |
 | Mocetinostat | IC50 | 10000.0 [1], 25000.0 [2], 35000.0 [3] |
 | Quisinostat | IC50 | 64.4 [1], 169.0 [2], 217.0 [3] |
| Quisinostat | Ki | 0.5 [1], 24.0 [2] |
 | Dacinostat | IC50 | 3.84 [1], 400.0 [2] |
| Dacinostat | Ki | 340.0 [1] |
 | Ricolinostat | IC50 | 100.0 [1], 254.0 [2], 5000.0 [3] |
 | 4-Acetamido-N-(2-amino-5-thiophen-2-ylphenyl)benzamide | IC50 | 10000.0 [1], 20000.0 [2] |
 | N-Hydroxy-3-[1-(phenylthio)methyl-1H-1,2,3-triazol-4-yl]benzamide | IC50 | 44.0 [1], 70.0 [2], 628.0 [3], 746.0 [4] |
 | Scriptaid | IC50 | 300.0 [1], 6810.0 [2] |
| Scriptaid | Ki | 105.0 [1] |
 | Largazole | IC50 | 1068.0 [1], 10000.0 [2], 30000.0 [3] |
 | 9,9,9-Trifluoro-8-Oxo-N-Phenylnonanamide | IC50 | 1500.0 [1] |
| 9,9,9-Trifluoro-8-Oxo-N-Phenylnonanamide | Ki | 33.0 [1], 7300.0 [2] |
 | N-Hydroxy-2,2-diphenylacetamide | IC50 | 45000.0 [1], 66000.0 [2] |
 | N-Hydroxy-6-[(2S,5S,8S,11S)-8-(1H-indol-3-ylmethyl)-2-methyl-11-(2-methylpropyl)-3,6,9,13-tetraoxo-1,4,7,10-tetrazacyclotridec-5-yl]hexanamide | IC50 | 130.0 [1], 133.0 [2] |
 | N-[4-[[3-Azido-5-(azidomethyl)phenyl]methoxy]phenyl]-N'-hydroxyoctanediamide | IC50 | 7340.0 [1] |
| N-[4-[[3-Azido-5-(azidomethyl)phenyl]methoxy]phenyl]-N'-hydroxyoctanediamide | Ki | 6590.0 [1] |
 | 1-(1-Phenyl-1H-1,2,3-triazole-4-ylmethyl)-3-hydroxypyridine-2(1H)-thione | IC50 | 1570.0 [1] |
 | (5R,8S,11S)-5-Methyl-8-propan-2-yl-11-[(E)-4-sulfanylbut-1-enyl]-10-oxa-3,17-dithia-7,14,19,20-tetrazatricyclo[14.2.1.12,5]icosa-1(18),2(20),16(19)-triene-6,9,13-trione | IC50 | 102.0 [1], 228.4 [2] |
 | Abexinostat | Ki | 280.0 [1] |
 | Pracinostat | Ki | 16.0 [1], 48.0 [2] |
 | Givinostat | Ki | 39.0 [1] |
 | 3-Hydroxypyridine-2-thiol | IC50 | 3675.0 [1] |
 | CID 53344908 | IC50 | 3600.0 [1] |
| CID 53344908 | Ki | 2706.0 [1] |
 | N-Hydroxy-4-[(14-methyl-13,15-dioxo-9,12,14-triazatetracyclo[10.3.1.02,10.03,8]hexadeca-2(10),3,5,7-tetraen-9-yl)methyl]benzamide | IC50 | 250.0 [1] |
| N-Hydroxy-4-[(14-methyl-13,15-dioxo-9,12,14-triazatetracyclo[10.3.1.02,10.03,8]hexadeca-2(10),3,5,7-tetraen-9-yl)methyl]benzamide | Ki | 173.0 [1] |
 | Azumamide E | IC50 | 3700.0 [1] |
| Azumamide E | Ki | 4400.0 [1] |
 | N-Hydroxy-4-phenylbutanamide | IC50 | 4000.0 [1] |
| N-Hydroxy-4-phenylbutanamide | Ki | 1850.0 [1] |
 | N-(Quinolin-8-YL)-6-(2-sulfanylacetamido)hexanamide | IC50 | 6120.0 [1] |
 | N-(2-Aminophenyl)-4-[1-[2-(3-thienyl)ethyl]-1H-1,2,3-triazol-4-yl]benzamide | IC50 | 30000.0 [1], 100000.0 [2] |
 | N-Hydroxy-4-methoxy-3-phenylmethoxybenzamide | IC50 | 23.9 [1], 27.0 [2] |
 | N'-Hydroxy-N-[3-(1-phenyltriazol-4-yl)phenyl]octanediamide | IC50 | 2780.0 [1] |
 | Largazole Thiol | IC50 | 102.0 [1] |
 | 6-(1-Adamantylcarbamoylamino)-N-hydroxyhexanamide | IC50 | 3410.0 [1], 6800.0 [2] |
 | CID 24853793 | IC50 | 1.0 [1], 5000.0 [2] |
 | N-(4-Hydroxybiphenyl-3-yl)benzamide | IC50 | 50000.0 [1] |
 | (2r)-2-Amino-3-(2,4-Dichlorophenyl)-1-(1,3-Dihydro-2h-Isoindol-2-Yl)propan-1-One | IC50 | 90.0 [1], 1090.0 [2] |
 | N-[1-[[3-Azido-5-(azidomethyl)phenyl]methyl]pyrazol-4-yl]-N'-hydroxyoctanediamide | IC50 | 17.0 [1] |
 | (E)-N-Hydroxy-3-[2-(2-phenylethyl)-1-(2-pyrrolidin-1-ylethyl)benzimidazol-5-yl]prop-2-enamide | Ki | 82.0 [1], 95.0 [2] |
 | Hdac8-IN-1 | IC50 | 27.0 [1], 27.2 [2] |
 | (2S)-N'-Hydroxy-2-[[(2S)-5-oxopyrrolidine-2-carbonyl]amino]-N-phenyloctanediamide | IC50 | 93.0 [1], 137.0 [2] |
 | 5-(Pyridin-4-YL)-1H-imidazole-2-thiol | IC50 | 500.0 [1] |
 | 2-Hydroxy-7-phenyl-2,4,6-cycloheptatriene-1-one | Ki | 0.53 [1], 1.09 [2] |
 | (2R)-5-Oxo-N-[(2S)-1-oxo-7-sulfanyl-1-[3-(trifluoromethyl)anilino]heptan-2-yl]pyrrolidine-2-carboxamide | IC50 | 316.0 [1] |
 | (E)-N-Hydroxy-3-[4-(4-hydroxyphenyl)phenyl]prop-2-enamide | IC50 | 162.0 [1], 590.0 [2] |
 | N-(2-Amino-5-thiophen-2-ylphenyl)-4-methoxybenzamide | IC50 | 20000.0 [1] |
 | (3S,6S,9S,13S)-3-(1H-Indol-3-ylmethyl)-9-methyl-13-(2-methylpropyl)-6-(6-oxooctyl)-1,4,7,10-tetrazacyclotridecane-2,5,8,11-tetrone | IC50 | 2200.0 [1] |
 | (4S,7S,10S,13S)-7-(1H-Indol-3-ylmethyl)-4-(2-methylpropyl)-10-(6-oxooctyl)-1,5,8,11-tetrazabicyclo[11.3.0]hexadecane-2,6,9,12-tetrone | IC50 | 15.0 [1], 1500.0 [2] |
 | (3S,6S,9S,13S)-3-(1H-Indol-3-ylmethyl)-9,10-dimethyl-13-(2-methylpropyl)-6-(6-oxooctyl)-1,4,7,10-tetrazacyclotridecane-2,5,8,11-tetrone | IC50 | 2000.0 [1], 2200.0 [2] |
 | 6-[(2S,5S,8S,11S)-8-(1H-Indol-3-ylmethyl)-2-methyl-11-(2-methylpropyl)-3,6,9,13-tetraoxo-1,4,7,10-tetrazacyclotridec-5-yl]hexanoic acid | IC50 | 2300.0 [1] |
 | (2R,5S,8S,11S)-8-(1H-Indol-3-ylmethyl)-2-methyl-11-(2-methylpropyl)-5-(6-oxooctyl)-1,4,7,10,14,15-hexazabicyclo[10.3.0]pentadeca-12,14-diene-3,6,9-trione | IC50 | 105.0 [1], 110.0 [2] |
 | (3S,6R,9S,13S)-3-(1H-Indol-3-ylmethyl)-9-methyl-13-(2-methylpropyl)-6-(4-oxohexylsulfanylmethyl)-1,4,7,10-tetrazacyclotridecane-2,5,8,11-tetrone | IC50 | 4900.0 [1], 4920.0 [2] |
 | (3S,6R,9S,13S)-3-(1H-Indol-3-ylmethyl)-9-methyl-13-(2-methylpropyl)-6-(3-oxopentylsulfanylmethyl)-1,4,7,10-tetrazacyclotridecane-2,5,8,11-tetrone | IC50 | 10000.0 [1] |
 | 3-Hydroxy-1-benzyl-2(1H)-pyridinethione | IC50 | 1272.0 [1] |
 | N-Hydroxy-2-(1-methylpyrrole-2-carbonyl)-3,4-dihydro-1H-isoquinoline-6-carboxamide | IC50 | 2100.0 [1] |
 | 5-[4-[[3-Azido-5-(azidomethyl)benzoyl]amino]phenyl]-N-[7-(hydroxyamino)-7-oxoheptyl]-1,2-oxazole-3-carboxamide | IC50 | 651.0 [1] |
 | (1r,2r,3r)-2-[4-(5-Fluoranylpyrimidin-2-Yl)phenyl]-N-Oxidanyl-3-Phenyl-Cyclopropane-1-Carboxamide | IC50 | 1400.0 [1] |
 | 4-[4-[(3-Hydroxy-2-sulfanylidenepyridin-1-yl)methyl]phenyl]benzonitrile | IC50 | 2075.0 [1] |
 | 1-[[4-[4-(Dimethylamino)phenyl]phenyl]methyl]-3-hydroxypyridine-2-thione | IC50 | 2858.0 [1] |
 | 3-Hydroxy-1-[[4-(4-methylphenyl)phenyl]methyl]pyridine-2-thione | IC50 | 800.0 [1] |
 | 3-Hydroxy-1-[(4-phenylphenyl)methyl]pyridine-2-thione | IC50 | 4283.0 [1] |
 | 3-Hydroxy-1-[[4-(2-methylphenyl)phenyl]methyl]pyridine-2-thione | IC50 | 3105.0 [1] |
 | 1-[[1-[4-(Dimethylamino)phenyl]triazol-4-yl]methyl]-3-hydroxypyridine-2-thione | IC50 | 1868.0 [1] |
 | 3-[4-[(3-Hydroxy-2-sulfanylidenepyridin-1-yl)methyl]phenyl]benzonitrile | IC50 | 1701.0 [1] |
 | 3-Hydroxy-1-[[4-(3-methylphenyl)phenyl]methyl]pyridine-2-thione | IC50 | 2496.0 [1] |
 | N3-Hydroxy-N1-phenylbenzene-1,3-dicarboxamide | IC50 | 110.0 [1], 120.0 [2] |
 | N-(2-Aminophenyl)-5-[1-[2-(3-nitrophenyl)ethyl]triazol-4-yl]thiophene-2-carboxamide | IC50 | 100000.0 [1] |
 | (2S)-N'-Hydroxy-2-[[(2R)-5-oxopyrrolidine-2-carbonyl]amino]-N-[3-(trifluoromethyl)phenyl]octanediamide | IC50 | 32.9 [1], 33.0 [2] |
 | (2S)-N'-Hydroxy-2-[[(2S)-4-oxoazetidine-2-carbonyl]amino]-N-phenyloctanediamide | IC50 | 93.0 [1], 137.0 [2] |
 | (2S)-N'-Hydroxy-N-(3-methylphenyl)-2-[[(2R)-5-oxopyrrolidine-2-carbonyl]amino]octanediamide | IC50 | 52.0 [1] |
 | N-[[4-(Hydroxycarbamoyl)phenyl]methyl]-1-methylpyrrole-2-carboxamide | IC50 | 690.0 [1] |
 | (7R)-N-Hydroxy-7-[(4-pyridin-3-ylpyrimidin-2-yl)amino]-5,6,7,8-tetrahydronaphthalene-2-carboxamide | IC50 | 80.0 [1] |
 | N-Phenyl-N'-[(2,4,5-trimethyl-3,6-dioxocyclohexa-1,4-dien-1-yl)methoxy]octanediamide | IC50 | 3842.0 [1] |
| N-Phenyl-N'-[(2,4,5-trimethyl-3,6-dioxocyclohexa-1,4-dien-1-yl)methoxy]octanediamide | Ki | 250.0 [1] |
 | N-Hydroxy-3-[(4-pyridin-3-ylpyrimidin-2-yl)amino]-1,2,3,4-tetrahydroquinoline-6-carboxamide | IC50 | 470.0 [1] |
 | 1-(4-(Pyridin-4-yl)benzyl)-3-hydroxypyridine-2-thione | IC50 | 2780.0 [1] |
 | 1-[6-(4-Phenyl-1H-1,2,3-triazole-1-yl)hexyl]-3-hydroxypyridine-2(1H)-thione | IC50 | 6751.0 [1], 6791.0 [2] |
 | 1-[5-[4-(3-Methylphenyl)-1H-1,2,3-triazole-1-yl]pentyl]-3-hydroxypyridine-2(1H)-thione | IC50 | 1660.0 [1] |
 | 1-[5-[4-(4-Cyanophenyl)-1H-1,2,3-triazole-1-yl]pentyl]-3-hydroxypyridine-2(1H)-thione | IC50 | 1465.0 [1] |
Calculator
